Gao Ping, Tao Xinchen, Luo Ge, Yao Yuanyuan, Chen Congcong, Zhang Lifang, Yu Shui, Gong Ming, Huang Man, Chen Jingyu, Yan Min
Department of Anesthesiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Department of Intensive Care Unit, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
J Thorac Dis. 2025 Jul 31;17(7):4512-4523. doi: 10.21037/jtd-2024-2273. Epub 2025 Jul 9.
Lung transplantation (LTx) is the definitive treatment for patients with end-stage lung diseases, but its application in pediatrics is limited by donor scarcity and surgical complexity. There is a general lack of experience and consensus on anesthetic management during LTx in children with bronchiolitis obliterans syndrome (BOS). We summarized the data of children undergoing LTx with BOS after hematopoietic stem cell transplantation (HSCT) at The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU) to devise an anesthetic management strategy and describe practical experience.
Children with BOS who underwent LTx at SAHZU from January 2021 to September 2023 were reviewed. Data on demographics, perioperative clinical parameters, and outcomes were collected and recorded. Transesophageal echocardiography (TEE) guided the dynamic evaluation of cardiac function, volume management, and pulmonary vascular anastomosis. Pulmonary artery catheters (PACs) were used to monitor pulmonary artery pressure (PAP).
Ten children with BOS post-HSCT underwent LTx, including eight males and two females. One patient had a single LTx, and the others had double LTx. All children received allogeneic red blood cell (RBC) infusion. Three received continuous renal replacement therapy (CRRT) during the operation. Postoperative mechanical ventilation time was 2 (IQR, 2-24) days. Extracorporeal membrane oxygenation (ECMO) time was 12 (IQR, 6-12) hours. Four patients developed acute kidney injury (AKI) within 48 hours, and primary graft dysfunction grade 3 (PGD3) occurred in 10% within 48-72 hours. Intensive care unit (ICU) stay was 9 (IQR, 6-40) days, and the 30-day survival rate was 100%.
Preoperative evaluation, volume management, hemodynamic monitoring, TEE, and ECMO application are the key points that anesthesiologists should pay attention to in such cases.
肺移植(LTx)是终末期肺部疾病患者的确定性治疗方法,但其在儿科的应用受到供体稀缺和手术复杂性的限制。对于闭塞性细支气管炎综合征(BOS)患儿的肺移植麻醉管理,普遍缺乏经验和共识。我们总结了浙江大学医学院附属第二医院(SAHZU)接受造血干细胞移植(HSCT)后发生BOS并接受肺移植的患儿的数据,以制定麻醉管理策略并描述实际经验。
回顾了2021年1月至2023年9月在SAHZU接受肺移植的BOS患儿。收集并记录了人口统计学、围手术期临床参数和结局的数据。经食管超声心动图(TEE)用于指导心脏功能、容量管理和肺血管吻合的动态评估。肺动脉导管(PACs)用于监测肺动脉压(PAP)。
10例HSCT后发生BOS的患儿接受了肺移植,其中8例男性,2例女性。1例患者接受单肺移植,其余患者接受双肺移植。所有患儿均接受了异体红细胞(RBC)输注。3例在手术期间接受了持续肾脏替代治疗(CRRT)。术后机械通气时间为2(四分位间距,2 - 24)天。体外膜肺氧合(ECMO)时间为12(四分位间距,6 - 12)小时。4例患者在48小时内发生急性肾损伤(AKI),10%的患者在48 - 72小时内发生3级原发性移植功能障碍(PGD3)。重症监护病房(ICU)住院时间为9(四分位间距,6 - 40)天,30天生存率为100%。
术前评估、容量管理、血流动力学监测、TEE和ECMO的应用是麻醉医生在这类病例中应关注的要点。